MS SB2340

Extends the repeal date of Harper Grace's Law from July 1, 2024 to July 1, 2027, allowing continued research and medical use of cannabidiol (CBD) solution for debilitating epileptic conditions.

Authorizes the National Center for Natural Products Research at the University of Mississippi and the Mississippi Agricultural and Forestry Experiment Station at Mississippi State University to produce cannabis plants for CBD research.

Permits the University of Mississippi Medical Center Pharmacy to dispense CBD solution prepared from cannabis extract, either from university research or hemp produced under state law, after patients or guardians sign hold-harmless agreements.

Provides affirmative defense against marijuana possession charges for patients with debilitating epileptic conditions or their guardians who possess CBD solution pursuant to physician orders.

Prohibits state agencies and law enforcement from initiating child removal proceedings based solely on possession or use of authorized CBD solution.